Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

Keith A. Stewart; Vincent S. Rajkumar; Meletios A. Dimopoulos; Tamas Masszi; Ivan Spicka; Albert Oriol; Georgi Mihaylov; Vesselina Goranova-Marinova

A 1454

Детайли

Източник: New England Journal of Medicine, The; New England Journal of Medicine, The

Системен №: 9872

Действия

APA Chicago / Turabian (16th edition) Harvard MLA (7th edition)

Stewart, K., Rajkumar, V., Dimopoulos, M., Masszi, T., Spicka, I., Oriol, A., Mihaylov, G., Goranova-Marinova, V. Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma, , .

Stewart, K., Rajkumar, V., Dimopoulos, M., Masszi, T., Spicka, I., Oriol, A., Mihaylov, G., Goranova-Marinova, V. . Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma. : , .

Stewart, K., Rajkumar, V., Dimopoulos, M., Masszi, T., Spicka, I., Oriol, A., Mihaylov, G., Goranova-Marinova, V. () Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma, :

Stewart, K., Rajkumar, V., Dimopoulos, M., Masszi, T., Spicka, I., Oriol, A., Mihaylov, G., & Goranova-Marinova, V. (). Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma. New England Journal of Medicine, The; New England Journal of Medicine, The.

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

Детайли

Допълнителна информация

Действия